Use of sodium iodide symporter expression in differentiated thyroid carcinomas

Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis

(2010) Luc G.T. Morris et al.   AMERICAN JOURNAL OF SURGERY

Thyroid Cancer Epidemiology and Prognostic Variables

(2010) J.A. Sipos et al.   CLINICAL ONCOLOGY

Are the Clinical and Pathological Features of Differentiated Thyroid Carcinoma Really Changed over the Last 35 Years? Study on 4187 Patients from a Single Italian Institution to Answer this Question

(2010) Rossella Elisei et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Câncer da tiróide: aumento na ocorrência da doença ou simplesmente na sua detecção?

(2009) Laura Sterian Ward et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

The BRAFV600E Oncogene Induces Transforming Growth Factor   Secretion Leading to Sodium Iodide Symporter Repression and Increased Malignancy in Thyroid Cancer

(2009) G. Riesco-Eizaguirre et al.   CANCER RESEARCH

Prognostic Factors and Therapeutic Strategies for Differentiated Carcinomas of the Thyroid

(2009) Yasuhiro ITO et al.   ENDOCRINE JOURNAL

Molecular Markers in Thyroid Cancer Diagnostics

(2009) Meredith A. Kato et al.   SURGICAL CLINICS OF NORTH AMERICA

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

(2009) David S. Cooper et al.   THYROID

Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600Emutation dependency

(2008) Carla Espadinha et al.   CLINICAL ENDOCRINOLOGY

BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer

(2008) C. Romei et al.   ENDOCRINE-RELATED CANCER

An Updated Systematic Review and Commentary Examining the Effectiveness of Radioactive Iodine Remnant Ablation in Well-Differentiated Thyroid Cancer

(2008) Anna M. Sawka et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers

(2008) Isabelle Peyrottes et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Association of Low Sodium-Iodide Symporter Messenger Ribonucleic Acid Expression in Malignant Thyroid Nodules with Increased Intracellular Protein Staining

(2008) Ana Karina M. B. Sodré et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM